Pharmacokinetics, Safety, and Tolerability of Vortioxetine Following Single- and Multiple-Dose Administration in Healthy Japanese Adults.

about

Pharmacokinetics, Safety, and Tolerability of Vortioxetine Following Single- and Multiple-Dose Administration in Healthy Japanese Adults.

Item

http://www.wikidata.org/entity/Q47760557

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Pharmacokinetics, Safety, and ...... on in Healthy Japanese Adults.

@en

Pharmacokinetics, Safety, and ...... on in Healthy Japanese Adults.

@nl

type

Item

label

Pharmacokinetics, Safety, and ...... on in Healthy Japanese Adults.

@en

Pharmacokinetics, Safety, and ...... on in Healthy Japanese Adults.

@nl

prefLabel

Pharmacokinetics, Safety, and ...... on in Healthy Japanese Adults.

@en

Pharmacokinetics, Safety, and ...... on in Healthy Japanese Adults.

@nl

P1476

Pharmacokinetics, Safety, and ...... on in Healthy Japanese Adults.

@en

P2093

Akira Nishimura

http://www.w3.org/2001/XMLSchema#string

Koki Nakamura

http://www.w3.org/2001/XMLSchema#string

Kumi Matsuno

http://www.w3.org/2001/XMLSchema#string

Yutaka Aritomi

http://www.w3.org/2001/XMLSchema#string

P2860

A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder

Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.

Depression in older adults.

Inhibition of CYP2D6 activity by bupropion.

Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder.

A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder.

A randomized, double-blind trial of 2.5 mg and 5 mg vortioxetine (Lu AA21004) versus placebo for 8 weeks in adults with major depressive disorder.

Vortioxetine (Lu AA21004), a novel multimodal antidepressant, enhances memory in rats.

CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants.

P304

319-331

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CPDD.381

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28941196

http://www.w3.org/2001/XMLSchema#string

P932

5900865

http://www.w3.org/2001/XMLSchema#string